Female Sexual Arousal Disorder

Female Sexual Arousal Disorder

Female sexual dysfunction (FSD) correctly defined as any type of anxiety or distress that is the result of sexual pain, orgasm difficulties, and or curb in sexual excitement or arousal.

Defining female sexual disorder(FSD):

Complex interactions between both biological and psychosocial processes create the human sexual response. Some factors that can influence the sexual interest or excitement such as: cultural practices, the individuals themselves, as well as the time, setting, and circumstance surrounding the sexual urge.

Due to the high variability that exists in the definitions and diagnostic categories of female sexual dysfunction (FSD), there are very limited study or test data available on the incidence and prevalence of these problems.

Even so, the incidence of female dysfunctions (FDs), has been evaluated to be within the range of 25.5 to as much as 93%. More specifically, a 2006 wide study data revealed that 65% and 32% of females experience desire and arousal problems or difficulties, simultaneously, whereas 35% report orgasmic dysfunctions, and 22% experience sexual pain.

Major types of females sexual disorders:

FSDs that alter a women’s sexual excitement and or arousal can be further divided into three major types, of which include:

  • Female hypoactive sexual desire disorder (HSDD).
  • Female sexual arousal disorder (FSAD).
  • Female sexual arousal interest dysfunction (FSAID).

HSDD is categorized by a distressing low sexual interest that is not the result of a medical or psychiatric condition, or substance abuse. Comparatively, FSAD is defined as an inability to achieve and or keep up genital arousal consistently, despite receiving adequate stimulation.

As of 2013, FSIAD was discovered as a new FSD category that is the combination of both the altered desire symptoms of HSSD and the insufficient arousal component of FSAD.

Female orgasmic disorders:

Another major category of FSDs is female orgasmic disorders (FODs), which are the second most prevalent type of sexual disorder in females. FODs are described as the difficulty, delay, or unable to reach orgasm at the time of sexual activity. An orgasm elaborated as a sensation of intense pleasure, well-being, and positive feelings that results from a physiologic reaction.

In addition to these sensations or feelings, an orgasm is also accumulated by involuntary rhythmic contractions of the pelvic striated vaginal musculature, uterus and or anus, an altered state of consciousness, and also reduce in sexually excitement vasocaongestion levels. Neurologically, orgasms have been shown to uplift activation into the periventricular nucleus of the hypothalamus, periaqueductal gray area of the middle of brain, hippocampus, and cerebellum.

Female sexual pain:

There are currently 4 major clinical conditions that are considered as female sexual pain disorders, which are:

  • Dyspareunia.
  • Vaginismus.
  • Vestibulodynia.
  • Vulvodynia.

Dyspareunia, which is described as genital pain during and or after sexual penetration, is estimated to have a prevalence within the range of 6.5% to 45% in older females and between 14% and 35% in younger females.

Vaginismus, which causes the involuntary spasm and or tension of the perineal and levator muscles, makes intercourse extremely problematic and, in some cases, not possible. Vestibulodynia causes severe pain in the female that can arise upon touch or attempted vaginal entry within the vestibule. Lastly, Vulvodynia is connected with chronic neuropathic –like pain into the vulvar area. The pain caused by Vulvodynia can persist independent of physical touch.

Regardless of the type of female sexual pain disorder (FSD), it is much important for treating clinicians to complete a comprehensive pain and psychosocial evaluation for their patients. These evaluations should include the use of rating scales to allow clinicians to establish a baseline and track patient progress from time to time.

Best treatment for female orgasmic disorders:

Several different therapeutic approaches, medication, surgery are available for the management of FSDs. For FSDs that are associated with sexual desire or excitement, hormonal and or non-hormonal treatment modalities are available. Some of the hormonal therapeutic or medication treatments that can be used to enhance the symptoms of HSDD and FSAD include systemic or vaginal estrogen treatment, androgen supplementation, or selective estrogen receptor modulators (SERMs) etc.

 Non-hormonal treatment options for FSAD and HSDD are:

  • Psychotherapy, serotonin agonists,
  • Dopaminergic drugs,
  • Phosphodiesterase 5 (PDE5) inhibitors,
  • Eros-clitoral therapy device (Erox-CTD),
  • Antidepressants and nutritional supplements.

The treatment of FSDs are limited, as current management strategies are limited to cognitive behavioral therapy (CBT). This type of therapeutic treatment mainly focused on decreasing the occurrence or anxiety-provoking thoughts that might lead to sexual difficulties or problems and instead divert the woman’s attention to enhancing intimacy and trust. Buy best females disorder treatment medicine online from Indian pharmacies.

Additional ways of treatment that may increase or maintain FSD symptoms such as: Kegel exercises, Bibliotherapy, Communications skills training, and Direct clitoral stimulation.

Leave a Reply

Your email address will not be published.